Outlook Therapeutics Inc
NASDAQ:OTLK

Watchlist Manager
Outlook Therapeutics Inc Logo
Outlook Therapeutics Inc
NASDAQ:OTLK
Watchlist
Price: 0.5614 USD -2.23%
Market Cap: 24.9m USD

Wall Street
Price Targets

OTLK Price Targets Summary
Outlook Therapeutics Inc

Wall Street analysts forecast OTLK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OTLK is 9.69 USD with a low forecast of 1.01 USD and a high forecast of 22.05 USD.

Lowest
Price Target
1.01 USD
80% Upside
Average
Price Target
9.69 USD
1 626% Upside
Highest
Price Target
22.05 USD
3 828% Upside
Outlook Therapeutics Inc Competitors:
Price Targets
BAVA
Bavarian Nordic A/S
28% Upside
CGON
CG Oncology Inc
51% Upside
TECX
AVROBIO Inc
313% Upside
ADMA
ADMA Biologics Inc
48% Upside
87S
Roivant Sciences Ltd
9% Upside
005690
Pharmicell Co Ltd
23% Upside
KALV
Kalvista Pharmaceuticals Inc
127% Upside
CELC
Celcuity Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Outlook Therapeutics Inc

For the last 10 years the compound annual growth rate for Outlook Therapeutics Inc's revenue is -12%. The projected CAGR for the next 3 years is 210%.

-12%
Past Growth
210%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Outlook Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Outlook Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OTLK's stock price target?
Price Target
9.69 USD

According to Wall Street analysts, the average 1-year price target for OTLK is 9.69 USD with a low forecast of 1.01 USD and a high forecast of 22.05 USD.

What is Outlook Therapeutics Inc's Revenue forecast?
Projected CAGR
210%

For the last 10 years the compound annual growth rate for Outlook Therapeutics Inc's revenue is -12%. The projected CAGR for the next 3 years is 210%.

Back to Top